AMBBY:OTC-Ambu A/S (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 18.62

Change

-0.38 (-2.00)%

Market Cap

USD 5.76B

Volume

133.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-24 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
SEMHF Siemens Healthineers AG

N/A

USD 67.69B
SMMNY Siemens Healthineers AG ADR

N/A

USD 67.09B
RYLPF Koninklijke Philips N.V

N/A

USD 26.13B
SONVF Sonova Holding AG

N/A

USD 19.66B
SONVY Sonova Holding AG

N/A

USD 19.16B
CHEOY CochLear Ltd ADR

N/A

USD 13.97B
CHEOF Cochlear Limited

N/A

USD 13.46B
SNNUF Smith & Nephew plc

N/A

USD 11.57B
WILYY Demant A/S ADR

N/A

USD 10.38B
WILLF Demant A/S

N/A

USD 10.35B

ETFs Containing AMBBY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.70% 75% C 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.70% 74% C 75% C
Trailing 12 Months  
Capital Gain 17.25% 74% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.25% 73% C 70% C-
Trailing 5 Years  
Capital Gain 14.01% 73% C 70% C-
Dividend Return 0.90% 9% A- 4% F
Total Return 14.91% 74% C 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 13.54% 62% D 60% D-
Dividend Return 13.67% 62% D 56% F
Total Return 0.12% 9% A- 5% F
Risk Return Profile  
Volatility (Standard Deviation) 64.12% 53% F 43% F
Risk Adjusted Return 21.31% 66% D+ 56% F
Market Capitalization 5.76B 92% A 85% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector